Related references
Note: Only part of the references are listed.A novel plant-derived compound is synergistic with 5-fluorouracil and has increased apoptotic activity through autophagy in the treatment of actinic keratoses
Cameron E. West et al.
JOURNAL OF DERMATOLOGICAL TREATMENT (2022)
Pemetrexed - First-Line Therapy for Non-Squamous Non-Small Cell Lung Cancer: A Review of Patent Literature
Pratik Ashwinbhai Vora et al.
RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY (2021)
MET inhibitor, capmatinib overcomes osimertinib resistance via suppression of MET/Akt/snail signaling in non-small cell lung cancer and decreased generation of cancer-associated fibroblasts
Kaibin Zhu et al.
AGING-US (2021)
Resistance mechanisms of epidermal growth factor receptor tyrosine kinase inhibitors in non-small cell lung cancer patients: A meta-analysis
Nobuaki Kobayashi et al.
THORACIC CANCER (2021)
Novel Resistance Mechanisms to Osimertinib Analysed by Whole-Exome Sequencing in Non-Small Cell Lung Cancer
Zhen Wu et al.
CANCER MANAGEMENT AND RESEARCH (2021)
Molecular biomarkers in early stage lung cancer
Maria Rodriguez et al.
TRANSLATIONAL LUNG CANCER RESEARCH (2021)
Tackling Drug Resistance in EGFR Exon 20 Insertion Mutant Lung Cancer
Laura Pacini et al.
PHARMACOGENOMICS & PERSONALIZED MEDICINE (2021)
GZ17-6.02 initiates DNA damage causing autophagosome-dependent HDAC degradation resulting in enhanced anti-PD1 checkpoint inhibitory antibody efficacy
Laurence Booth et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2020)
Neratinib degrades MST4 via autophagy that reduces membrane stiffness and is essential for the inactivation of PI3K, ERK1/2, and YAP/TAZ signaling
Paul Dent et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2020)
GZ17-6.02 and Doxorubicin Interact to Kill Sarcoma Cells via Autophagy and Death Receptor Signaling
Laurence Booth et al.
FRONTIERS IN ONCOLOGY (2020)
Osimertinib versus platinum-pemetrexed for patients with EGFR T790M advanced NSCLC and progression on a prior EGFR-tyrosine kinase inhibitor: AURA3 overall survival analysis
V. A. Papadimitrakopoulou et al.
ANNALS OF ONCOLOGY (2020)
Neratinib inhibits Hippo/YAP signaling, reduces mutant K-RAS expression, and kills pancreatic and blood cancer cells
Paul Dent et al.
ONCOGENE (2019)
Potent Antitumor Effects of a Combination of Three Nutraceutical Compounds
Vikalp Vishwakarma et al.
SCIENTIFIC REPORTS (2018)
PDE5 inhibitors enhance the lethality of pemetrexed through inhibition of multiple chaperone proteins and via the actions of cyclic GMP and nitric oxide
Laurence Booth et al.
ONCOTARGET (2017)
A review on traditional uses, phytochemistry, pharmacology, pharmacokinetics and toxicology of the genus Peganum
Shuping Li et al.
JOURNAL OF ETHNOPHARMACOLOGY (2017)
HDAC inhibitors enhance neratinib activity and when combined enhance the actions of an anti-PD-1 immunomodulatory antibody in vivo
Laurence Booth et al.
ONCOTARGET (2017)
HDAC inhibitors enhance the immunotherapy response of melanoma cells
Laurence Booth et al.
ONCOTARGET (2017)
The HDAC inhibitor AR42 interacts with pazopanib to kill trametinib/dabrafenib-resistant melanoma cells in vitro and in vivo
Laurence Booth et al.
Oncotarget (2017)
Complementary and alternative medicine use among cancer patients in Palestine with special reference to safety-related concerns
Mohammed S. Ali-Shtayeh et al.
JOURNAL OF ETHNOPHARMACOLOGY (2016)
[Pemetrexed plus Sorafenib] lethality is increased by inhibition of ERBB1/2/3-PI3K-NFκB compensatory survival signaling
Laurence Booth et al.
ONCOTARGET (2016)
The afatinib resistance of in vivo generated H1975 lung cancer cell clones is mediated by SRC/ERBB3/c-KIT/c-MET compensatory survival signaling
Laurence Booth et al.
ONCOTARGET (2016)
Sorafenib Enhances Pemetrexed Cytotoxicity through an Autophagy-Dependent Mechanism in Cancer Cells
M. Danielle Bareford et al.
CANCER RESEARCH (2011)
Pemetrexed Indirectly Activates the Metabolic Kinase AMPK in Human Carcinomas
Scott B. Rothbart et al.
CANCER RESEARCH (2010)
The Beta-Carboline Alkaloid Harmine inhibits BCRP and Can Reverse Resistance to the Anticancer Drugs Mitoxantrone and Camptothecin in Breast Cancer Cells
Yonggang Ma et al.
PHYTOTHERAPY RESEARCH (2010)
Specific inhibition of cyclin-dependent kinases and cell proliferation by harmine
YC Song et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
Genotoxic and recombinogenic activities of the two β-carboline alkaloids harman and harmine in Saccharomyces cerevisiae
JM Boeira et al.
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS (2002)
Share Paper
